Harrow (HROW) Gross Margin (2013 - 2026)

Harrow's (HROW) quarterly Gross Margin came in at 61.18% in Q1 2026, down 636.0% year-on-year from 11.41% in Q1 2025, and down 22.82% quarter-over-quarter from 79.27% in Q4 2025.

Harrow (HROW) Gross Margin (2013 - 2026) Analysis & Trends

Harrow's Gross Margin history runs 14 years deep, the most recent figure standing at 61.18% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 636.0% year-over-year to 61.18% in Q1 2026; TTM through Mar 2026 was 74.11%, a 42.0% decrease from a year earlier, with the FY2025 full-year figure at 75.05%, down 28.0% from the prior year.
  • Gross Margin retreated to 61.18% in Q1 2026 per HROW's latest filing, from 79.27% in the prior quarter.
  • Across five years, Gross Margin topped out at 79.27% in Q4 2025 and bottomed at 61.18% in Q1 2026.
  • The 5-year median for Gross Margin is 70.62% (2023), against an average of 71.73%.
  • Across the five-year window, Gross Margin surged 994 bps in 2024 and sank 636 bps in 2026, its largest moves.
  • Year by year, Gross Margin stood at 69.67% in 2022, then retreated by 1 bps to 68.91% in 2023, then grew by 14 bps to 78.85% in 2024, then rose by 1 bps to 79.27% in 2025, then fell by 23 bps to 61.18% in 2026.
  • Per Business Quant, the three latest HROW Gross Margin figures stand at 61.18% (Q1 2026), 79.27% (Q4 2025), and 75.28% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn 61.18%

Historic Data

Download Data
DateValue
Mar 31, 2026 61.18%
Dec 31, 2025 79.27%
Sep 30, 2025 75.28%
Jun 30, 2025 74.54%
Mar 31, 2025 67.54%
Dec 31, 2024 78.85%
Sep 30, 2024 75.60%
Jun 30, 2024 74.38%
Mar 31, 2024 69.49%
Dec 31, 2023 68.91%
Sep 30, 2023 70.62%
Jun 30, 2023 70.12%
Mar 31, 2023 68.31%
Dec 31, 2022 69.67%
Sep 30, 2022 70.55%
Jun 30, 2022 71.98%
Mar 31, 2022 73.04%
Dec 31, 2021 74.84%
Sep 30, 2021 73.56%
Jun 30, 2021 75.64%